Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
REPLICATION

Respiratory Syncytial Virus M2-1 Protein Requires Phosphorylation for Efficient Function and Binds Viral RNA during Infection

Tara L. Cartee, Gail W. Wertz
Tara L. Cartee
Department of Microbiology, University of Alabama School of Medicine, Birmingham, Alabama 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail W. Wertz
Department of Microbiology, University of Alabama School of Medicine, Birmingham, Alabama 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.75.24.12188-12197.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    MALDI-TOF analysis of M2-6His digestion products. (A) Representative trypsin digestion of M2-6His, identifying phosphorylated peptides. M2-6His was transfected into vTF7-3-infected HEp-2 cells. After partial purification with NiNTA beads, the M2-1 protein was separated by electrophoresis on an SDS–11% polyacrylamide gel, stained, excised from the gel, destained, dried, and cleaved with trypsin. The resultant peptides were analyzed by MALDI-TOF in linear mode (top). A duplicate sample was treated with CIP (1 U) for 30 min at 30°C and analyzed (bottom). In the bottom graph, a mass calibration standard (mass standard) was added to the reaction prior to analysis. (B) Potential phosphorylation sites between amino acids 53 and 68 of the M2-1 protein. Mutagenesis was performed on the residues that are underlined and in boldface.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Expression of M2-1 protein phosphorylation mutants. (A) Analysis of mutant proteins. HEp-2 cells, infected with vTF7-3, were either mock transfected or transfected with 5 μg of plasmids expressing M2-1 or the indicated phosphorylation mutants (S58A, S61A, T56A, or T56A S58A). The cells were labeled with either [35S]methionine and [35S]cysteine (35S) or inorganic [33P]phosphate (33P) for 3 h at 17 h p.t. Cytoplasmic extracts were prepared and precleared. Then proteins were immunoprecipitated with MAb ICI3, separated by SDS-PAGE, and subjected to autoradiography. After immunoprecipitation, the samples in lanes 13 and 14 were treated with 200 U of λ-PPase for 30 min at 30°C. The bracket indicates the position of the 33P-labeled coimmunoprecipitated material. (B) RS virus proteins. RS virus-infected (RS inf.) HEp-2 cells, harvested 24 h post infection, were prepared and immunoprecipitated as described for panel A, except the lysate was not precleared. (C) In vitro CKI phosphorylation of M2-1 protein. M2-1 protein produced in E. coli was incubated with CKI and [γ-33P]ATP for 30 min at 37°C. The protein was separated by SDS-PAGE on an 11% polyacrylamide gel and Coomassie stained (left) or subjected to autoradiography (right).

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Effect of M2-1 protein phosphorylation mutations on transcription. (A) Diagram of F/M2 replicon containing the authentic F/M2 gene junction and the expected products of transcription. (B) MVA-T7-infected HEp-2 cells were transfected with pF/M2, pN, pP, pL, and increasing amounts of M2-1 wt or mutant plasmids (0.15 to 0.6 μg), pT56A, pS58A, pS61A, or pT56AS58A. The cells were labeled for 5.5 h at 17 h p.t. with [3H]uridine in the presence of Act D. The purified RNAs were visualized by separation on an agarose-urea gel followed by fluorography. (C) Quantitation of percent readthrough products at each amount of input plasmid. Percent readthrough was determined by densitometric analysis and conversion to molar amounts of RNA based upon [3H]uridine incorporation. Rep, replication; le, leader; tr, trailer; ig, intergenic; AAAn, polyadenylate.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    RNA is coimmunoprecipitated with the M2-1 protein. (A) HEp-2 cells infected with vTF7-3 were either mock transfected or transfected with 5 μg of pM2-ORF1 or plasmids expressing mutant M2-1 proteins. The cells were labeled for 3 h at 17 h p.t. with inorganic [33P]phosphate. Immunoprecipitations were performed using MAb ICI3. The immunoprecipitated proteins were analyzed by SDS-PAGE on an 11% polyacrylamide gel followed by autoradiography. (B) Digestion of 33P-labeled component. Transfected (lane 3, mock; lanes 4 to 7, 5 μg of pM2-ORF1) and infected (lanes 1 and 2) cells were prepared as for panel A, except 5 μg of proteinase K (Prot K), 5 μg of RNase A, or 1 U of DNase RQI was added after immunoprecipitation as indicated, followed by incubation for 30 min at 37°C.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Analysis of coimmunoprecipitated RNA from an RSV infection. HEp-2 cells in 100-mm-diameter dishes were infected with RS virus (MOI = 10). The cells were labeled in the presence of Act D at 17 h postinfection for 5 h with inorganic [33P]phosphate. Cytoplasmic extracts were prepared, and lysates were either immunoprecipitated with MAbs to the M2-1, N, or F protein or analyzed for total RNA. RNAs were released from the immunoprecipitation mixture by boiling it in NTE. Immunoprecipitated and total RS virus RNAs were purified by phenol extraction and ethanol precipitation, followed by separation on an agarose-urea gel and fluorography. The locations of the various RS virus monocistronic and polycistronic RNAs are indicated on the left. +, present; −, absent.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    M2-1 protein–N protein interaction is unaffected by phosphorylation but is sensitive to RNase A digestion. HEp-2 cells infected with vTF7-3 were transfected with 5 μg of the indicated plasmid(s). The cells were labeled 17 h p.t. for 3 h with [35S]methionine and [35S]cysteine and immunoprecipitated with ICI3. RNase A (5 μg) and λ-PPase (200 U) were added as indicated, and samples were incubated at 37 or 30°C, respectively, for 30 min. Control samples for the RNase A and λPPase reactions were treated identically to the digested samples, except that the RNase A and λPPase were omitted. The treated and control samples were washed to remove any released protein and analyzed by electrophoresis on an 11% polyacrylamide gel. The percent M2-1–N interaction normalized to the wt interaction was quantified by densitometric analysis of autoradiograms for each sample.

Tables

  • Figures
  • Table 1.

    Characteristics of phosphorylated fragments observed with Lys C or trypsin cleavage

    ProteasePeptideObserved massaMass differencebInferred no. of phosphorylationsSensitivity to phosphatase treatmentc
    Trypsin53–833,287.65 (0.08)00−
    3,368.36 (0.79)80.711+
    3,448.30 (0.73)160.652+
    53–924,230.47 (0.77)00−
    4,309.47 (0.21)79.01+
    4,389.42 (0.24)158.952+
    Lys C53–802,910.23 (1.01)00−
    2,990.06 (0.84)79.831+
    3,070.06 (0.84)159.832+
    53–924,230.84 (1.14)00−
    4,311.95 (2.27)81.111+
    4,391.35 (1.69)160.512+
    • ↵a Numbers in parentheses represent the differences between the expected and observed masses. Masses are in daltons.

    • ↵b Mass differences equal to the observed mass of the phosphorylated peptide minus the observed mass of the unphosphorylated peptide. Masses are in daltons.

    • ↵c +, peak disappeared upon phosphatase treatment; −, no change in mass upon phosphatase treatment.

PreviousNext
Back to top
Download PDF
Citation Tools
Respiratory Syncytial Virus M2-1 Protein Requires Phosphorylation for Efficient Function and Binds Viral RNA during Infection
Tara L. Cartee, Gail W. Wertz
Journal of Virology Dec 2001, 75 (24) 12188-12197; DOI: 10.1128/JVI.75.24.12188-12197.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Respiratory Syncytial Virus M2-1 Protein Requires Phosphorylation for Efficient Function and Binds Viral RNA during Infection
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Respiratory Syncytial Virus M2-1 Protein Requires Phosphorylation for Efficient Function and Binds Viral RNA during Infection
Tara L. Cartee, Gail W. Wertz
Journal of Virology Dec 2001, 75 (24) 12188-12197; DOI: 10.1128/JVI.75.24.12188-12197.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

RNA, Viral
Respiratory Syncytial Viruses
Transcription, Genetic
Viral Proteins

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514